Green Plains, Tilly's See Activist Investor Action [MarketWatch]
Astria Therapeutics, Inc. (ATXS)
Company Research
Source: MarketWatch
Want to see it on more articles? Give your feedback below or email product@barrons.com thumb-stroke-medium thumb-stroke-medium Activist Holdings Green Plains Ancora Holdings reported holding 4,176,058 shares of the sustainable bioingredient maker, with 120,000 of those shares underlying exercisable options. On Feb. 6, Ancora and Green Plains entered a cooperation agreement that calls for Green Plains to initiate a formal review of its business “and evaluate strategic alternatives to maximize value.” As part of the agreement, Ancora will vote all its eligible Green Plains shares in support of board initiatives that come up for shareholder vote. However, Ancora may vote against Green Plains' board if its recommendations are opposed by Institutional Shareholder Services and Glass, Lewis. Otherwise, Ancora will abide by customary standstill provisions and limit its Green Plains stake to no more than 9.9%. It currently stands at 7%. Advertisement The cooperation agreement
Show less
Read more
Impact Snapshot
Event Time:
ATXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATXS alerts
High impacting Astria Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ATXS
News
- Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Astria Therapeutics, Inc. (NASDAQ: ATXS) had its price target lowered by analysts at HC Wainwright from $18.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
- Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Astria Therapeutics Appoints Sunil Agarwal to Its Board of DirectorsBusiness Wire
- Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
ATXS
Earnings
- 11/13/23 - Miss
ATXS
Sec Filings
- 4/22/24 - Form ARS
- 4/22/24 - Form DEFA14A
- 4/22/24 - Form DEF
- ATXS's page on the SEC website